ANGPT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, it was discovered that chronic myeloid leukaemia (CML) cells with a high amount of intracellular angiopoietin-1 (iANG-1) were resistant to dasatinib, nilotinib, imatinib and other TKIs.